Table 2.
Cancer Survivor Cohort(N = 8275) | Reference Cohort(N = 32,143) | ||
---|---|---|---|
Age at diagnosis/baseline | <45 | 742 (9%) | 3000 (9%) |
45–55 | 2673 (32%) | 10,272 (32%) | |
56–60 | 2447 (30%) | 9645 (30%) | |
>60 | 2413 (29%) | 9226 (29%) | |
Sex N (% male) | 5150 (62%) | 19,906 (62%) | |
Treatment * | Surgery | 7852 (95%) | NA |
Chemotherapy | 4323 (52%) | ||
Radiotherapy | 2453 (30%) | ||
Targeted | 507 (6%) | ||
Stage at diagnosis | I | 1835 (22%) | NA |
II | 1900 (23%) | ||
III | 3402 (41%) | ||
IV | 1138 (14%) | ||
Flex work (N (% yes)) | 316 (6%) | 1193 (6%) | |
Self-employed (N (% yes)) | 1242 (15%) | 5118 (16%) | |
Income before diagnosis | <500 | 153 (2%) | 597 (2%) |
500–20 k | 1764 (21%) | 6774 (21%) | |
20 k–35 k | 2071 (25%) | 8170 (26%) | |
35 k–50 k | 2048 (25%) | 7686 (24%) | |
>50 k | 2217 (27%) | 8800 (27%) |
* Percentages equal to treatment/diagnosis.